350404 <common-name>(5z)-5-[[3-(4-ethoxy-3-methylphenyl)-1-phenylpyrazol-4-yl]methylidene]-3-[(4-methylphenyl)methyl]-2-sulfanylidene-1,3-thiazolidin-4-one</common-name> <description>(5z)-5-[[3-(4-ethoxy-3-methylphenyl)-1-phenylpyrazol-4-yl]methylidene]-3-[(4-methylphenyl)methyl]-2-sulfanylidene-1,3-thiazolidin-4-one is a chemical compound with the formula C30H27N3O2S2. With an average molecular weight of 525.70 g/mol, (5z)-5-[[3-(4-ethoxy-3-methylphenyl)-1-phenylpyrazol-4-yl]methylidene]-3-[(4-methylphenyl)methyl]-2-sulfanylidene-1,3-thiazolidin-4-one is a heavy molecule.</description> <cas>623934-74-7</cas> <pubchem-id>1979911</pubchem-id> <chemical-formula>C30H27N3O2S2</chemical-formula> <weight>525.7</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T15:27:27Z</created-at> <updated-at type="dateTime">2026-08-31T15:27:27Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CCOC1=C(C=C(C=C1)C2=NN(C=C2C=C3C(=O)N(C(=S)S3)CC4=CC=C(C=C4)C)C5=CC=CC=C5)C</moldb-smiles> <moldb-formula>C30H27N3O2S2</moldb-formula> <moldb-inchi>InChI=1S/C30H27N3O2S2/c1-4-35-26-15-14-23(16-21(26)3)28-24(19-33(31-28)25-8-6-5-7-9-25)17-27-29(34)32(30(36)37-27)18-22-12-10-20(2)11-13-22/h5-17,19H,4,18H2,1-3H3/b27-17-</moldb-inchi> <moldb-inchikey>AXVSEEYZSCWPFV-PKAZHMFMSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">525.1544695</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>7.2</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM346297</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>(5z)-5-[[3-(4-ethoxy-3-methylphenyl)-1-phenylpyrazol-4-yl]methylidene]-3-[(4-methylphenyl)methyl]-2-sulfanylidene-1,3-thiazolidin-4-one</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Pyrazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0300709</sync-id> <structure-inchikey>AXVSEEYZSCWPFV-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>8002400000000000000000000000000001000014000000004040020002201000000000000020040000000040000000008010000000000000000000000000000800000000000000200000100003000000000000000000000000000000000800000001001100008000080001001080400000000000000000000041c0000000800000000000000000800000000100000000020000000000000000000000000000000000080100000000000020090000020200040000000000000000000000000001000000000000000010000000042800000220040000000000000140000000000040000000800080000000080020000000000a00000008</structure-fingerprint> <structure-pattern-fingerprint>7016c200cd32864081805b608138a3001900140081052040803da0408224c8cc7c023050139200000180410810c00000046102b5c28d3269016ce57988a04018c7510c111290160000901040137202010c46a59053a11f3340040e62442249040c7805af0048822460080484ddb4024d30868070011be14477180c60025100021ac048184ef082080c068258483c0008393d181244429e8a500008206040469650d3101390b0c0200a042969257c35104ac100028943084018844e304cc00212a070c8a6a4d80f3301c18485545342980c010111035850200d72020428002300907047100889016411080403591220820050243084c2040e1108908052000646</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAlAAAAKQAAAIABBgBgAAAAAQMGAGAAAAAC AggAKAAAAAMCBkAoAAAAAwQGQCgAAAADBAZAaAAAAAMDAQZAKAAAAAMEBkBo AAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQHQCgAAAADAwdAKAAAAAMDBkBoAAAA AwMBBkAoAAAAAwQGAGgAAAADAwEGACgAAAADBAYAKAAAAAMECAAoAAAAAwIH ACgAAAADAwYAKAAAAAMEEAAoAAAAAwIQACAAAAACBgBgAAAAAgIGQCgAAAAD BAZAaAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMB BgBgAAAAAQMGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZA aAAAAAMDAQZAaAAAAAMDAQYAYAAAAAEDCwABAAECAAIDIAMEaAwEBWgMBQZo DAYHaAwHCGgMBgkgCQpoDAoLaAwLDGgMDA1oDA0OIA4PKAIPECAQESgCEBIg EhMgExQoAhMVABIWABYXABcYaAwYGWgMGRpoDBobaAwbHGgMGh0ACx4gHh9o DB8gaAwgIWgMISJoDCIjaAwEJAAIA2gMDQloDBUPABwXaAwjHmgMQgUAAAAG AwgHBgUEBQoJDQwLBRAPFRMSBhgZGhscFwYfICEiIx4XBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:48:22Z</structure-indexed-at> </compound>